+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768303
  • Report
  • April 2019
  • Region: Global
  • 56 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • bluebird bio Inc
  • Celgene Corp
  • Magenta Therapeutics Inc
  • Minoryx Therapeutics sl
  • Nuo Therapeutics Inc
  • Nutra Pharma Corp
  • MORE
The global clinical trial report- “2019 Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Adrenoleukodystrophy (Schilder-Addison Complex). It presents in-depth analysis of Adrenoleukodystrophy (Schilder-Addison Complex) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Adrenoleukodystrophy (Schilder-Addison Complex).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Adrenoleukodystrophy (Schilder-Addison Complex) clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Adrenoleukodystrophy (Schilder-Addison Complex)

The research work is prepared through extensive and continuous research on Adrenoleukodystrophy (Schilder-Addison Complex) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Adrenoleukodystrophy (Schilder-Addison Complex) patients are identified
  • The report includes panorama of Adrenoleukodystrophy (Schilder-Addison Complex) clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Adrenoleukodystrophy (Schilder-Addison Complex) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • bluebird bio Inc
  • Celgene Corp
  • Magenta Therapeutics Inc
  • Minoryx Therapeutics sl
  • Nuo Therapeutics Inc
  • Nutra Pharma Corp
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials by Region
2.2.2 Average Enrollment of Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Adrenoleukodystrophy (Schilder-Addison Complex) Treatment, 2019

3. Region wise Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials
3.1 Asia Pacific Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials by Country
3.2 Europe Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials by Country
3.3 North America Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials by Country
3.4 Middle East and Africa Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials by Country
3.5 South and Central America Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials by Country

4. Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trial Trends
4.1 Start Year wise Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials
4.2 Phase wise Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials
4.3 Trial Status wise Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials
4.4 Trial Type wise Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials

5. Adrenoleukodystrophy (Schilder-Addison Complex) Average Enrollment Trends
5.1 Average Enrollment in Adrenoleukodystrophy (Schilder-Addison Complex) Trials by Year
5.2 Average Enrollment in Adrenoleukodystrophy (Schilder-Addison Complex) Trials by Phase
5.3 Average Enrollment in Adrenoleukodystrophy (Schilder-Addison Complex) Trials by Status
5.4 Average Enrollment in Adrenoleukodystrophy (Schilder-Addison Complex) Trials by Type of Trial

6. Companies Participating in Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials
6.1 Adrenoleukodystrophy (Schilder-Addison Complex) Trials by Sponsor Type
6.2 Adrenoleukodystrophy (Schilder-Addison Complex) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Adrenoleukodystrophy (Schilder-Addison Complex) Trials- Phase 1
7.2 Adrenoleukodystrophy (Schilder-Addison Complex) Trials- Phase 2
7.3 Adrenoleukodystrophy (Schilder-Addison Complex) Trials- Phase 3
7.4 Adrenoleukodystrophy (Schilder-Addison Complex) Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials and Enrolment
Figure 5: Europe - Country wise Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials and Enrolment
Figure 7: North America - Country wise Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials and Enrolment
Figure 9: Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials by Phase
Figure 10: Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials by Trial Status
Figure 11: Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials by Type
Figure 12: Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials by Sponsor Type
Figure 13: Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials by Leading Sponsors
Figure 14: Adrenoleukodystrophy (Schilder-Addison Complex) Average Enrollment by Phase
Figure 15: Adrenoleukodystrophy (Schilder-Addison Complex) Average Enrollment by Trial Status
Figure 16: Adrenoleukodystrophy (Schilder-Addison Complex) Average Enrollment by Type
Figure 17: Adrenoleukodystrophy (Schilder-Addison Complex)- Average Enrolment by Type of Sponsors
Figure 18: Adrenoleukodystrophy (Schilder-Addison Complex)- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials and Enrolment
Table 5: Europe - Country wise Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials and Enrolment
Table 7: North America - Country wise Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Adrenoleukodystrophy (Schilder-Addison Complex) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Adrenoleukodystrophy (Schilder-Addison Complex) Average Enrollment by Phase
Table 15: Adrenoleukodystrophy (Schilder-Addison Complex) Average Enrollment by Trial Status
Table 16: Adrenoleukodystrophy (Schilder-Addison Complex) Average Enrollment by Type
Table 17: Adrenoleukodystrophy (Schilder-Addison Complex)- Average Enrolment by Type of Sponsors
Table 18: Adrenoleukodystrophy (Schilder-Addison Complex)- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Asklepion Pharmaceuticals LLC
  • bluebird bio Inc
  • Celgene Corp
  • Magenta Therapeutics Inc
  • Minoryx Therapeutics sl
  • Nuo Therapeutics Inc
  • Nutra Pharma Corp
  • Orpheris Inc
  • SOM Biotech SL
  • Viking Therapeutics Inc
Note: Product cover images may vary from those shown
Adroll
adroll